Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Amara Sarwal

Showing results (31-40 of 37) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 37 results.
Journal of the American Society of Nephrology : JASN|January 21, 2026
Comparative Effectiveness of SGLT2i and GLP-1 RA on Kidney and Cardiovascular Outcomes by Kidney Failure RiskSydney E Hartsell, Guo Wei, Ravinder Singh, et al.
Renal Failure|June 26, 2023
Throwing stones: kidney stone incidence in living kidney donor candidates with increased metabolic riskAmara Sarwal, Junji Yamauchi, Divya Raghavan, et al.
Diabetes, Obesity & Metabolism|July 30, 2025
Glycemic therapies and the risk of gastrointestinal adverse events in veterans with type 2 diabetesAmara Sarwal, Ravinder Singh, Guo Wei, et al.
Diabetes, Obesity & Metabolism|January 31, 2025
Comparative effectiveness of insulin glargine, glucagon-like peptide-1 receptor agonists and sodium-glucose cotransporter-2 inhibitors in veterans with type 2 diabetesJincheng Shen, Amara Sarwal, Ravinder Singh, et al.
JAMA Network Open|October 13, 2025
Liraglutide vs Semaglutide vs Dulaglutide in Veterans With Type 2 DiabetesCatherine G Derington, Amara Sarwal, Guo Wei, et al.
Contemporary Clinical Trials|November 28, 2024
The Sit Less, Interact and Move More (SLIMM-2) Trial: Protocol for a randomized control trial of a sedentary behavior intervention, resistance training and semaglutide on sedentary behavior in persons with chronic kidney diseaseJesse C Christensen, Shuchi Anand, Glenn M Chertow, et al.
JACC. Heart Failure|June 26, 2025
Diabetes Therapy With SGLT2i After Heart Transplant: A Multi-Institutional AnalysisLina Brinker, Konstantinos Sideris, Guo Wei, et al.
Pageof 4

Showing results (31-40 of 37) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 37 results.
Journal of the American Society of Nephrology : JASN|January 21, 2026
Comparative Effectiveness of SGLT2i and GLP-1 RA on Kidney and Cardiovascular Outcomes by Kidney Failure RiskSydney E Hartsell, Guo Wei, Ravinder Singh, et al.
Renal Failure|June 26, 2023
Throwing stones: kidney stone incidence in living kidney donor candidates with increased metabolic riskAmara Sarwal, Junji Yamauchi, Divya Raghavan, et al.
Diabetes, Obesity & Metabolism|July 30, 2025
Glycemic therapies and the risk of gastrointestinal adverse events in veterans with type 2 diabetesAmara Sarwal, Ravinder Singh, Guo Wei, et al.
Diabetes, Obesity & Metabolism|January 31, 2025
Comparative effectiveness of insulin glargine, glucagon-like peptide-1 receptor agonists and sodium-glucose cotransporter-2 inhibitors in veterans with type 2 diabetesJincheng Shen, Amara Sarwal, Ravinder Singh, et al.
JAMA Network Open|October 13, 2025
Liraglutide vs Semaglutide vs Dulaglutide in Veterans With Type 2 DiabetesCatherine G Derington, Amara Sarwal, Guo Wei, et al.
Contemporary Clinical Trials|November 28, 2024
The Sit Less, Interact and Move More (SLIMM-2) Trial: Protocol for a randomized control trial of a sedentary behavior intervention, resistance training and semaglutide on sedentary behavior in persons with chronic kidney diseaseJesse C Christensen, Shuchi Anand, Glenn M Chertow, et al.
JACC. Heart Failure|June 26, 2025
Diabetes Therapy With SGLT2i After Heart Transplant: A Multi-Institutional AnalysisLina Brinker, Konstantinos Sideris, Guo Wei, et al.
Pageof 4